In this respect, it is notable that HIF2α is not mutated or overexpressed in AML, thus further suggesting that an intrinsic function exerted at specific hematopoietic stages may be exploited in leukemic cells. This evidence concerns the gene EPAS1 and acute myeloid leukemia.